The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for DemeTech sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
DemeTech is a medical device company that offers surgical sutures, mesh and bone wax products. The company uses its next-generation technology to meet the growing demands of medical society. It specializes in surgical sutures and blades and is known for its wound closure medical devices such as surgical sutures and hernia mesh, DemeMASK serving customers globally. These are designed to filter at least 95 percent of airborne particles, including bacterial particles. DemeTech is headquartered in Miami Lakes, Florida, the US.
The key metrics of DemeTech related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As DemeTech is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as DemeTech.
For a detailed understanding of the performance of DemeTech, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.